Cadence Biomedical, Inc. — Form D
Cadence Biomedical, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-24. The offering totals $1.3M, of which $960K was reported sold. Industry: Other.
Offering
- Filed: 2015-03-24
- Form: D
- Accession: 0001533465-15-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $960K
- Remaining: $340K
- Investors: 26
- Date of first sale: 2015-03-24
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-236549
Issuer
- Name: Cadence Biomedical, Inc.
- CIK: 0001533465
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2007
- Address: 3534 BAGLEY AVENUE N, SEATTLE, WA, 98103
- Phone: 206-659-0614
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Barry Hix | Director | Austin, TX |
| Barry Hix | Executive Officer | Austin, TX |
| David Caro | Director | New York, NY |
| John Castle | Director | Dallas, TX |
| Michael Hovanes | Director | Seattle, WA |
| Michael Hovanes | Executive Officer | Seattle, WA |
| Michael Hovanes | Promoter | Seattle, WA |
| Jason Schoen | Executive Officer | Seattle, WA |
| Rob Lewis | Director | Seattle, WA |
| Chie Kawahara | Executive Officer | Seattle, WA |
| Brian Glaister | Director | Seattle, WA |
| Brian Glaister | Executive Officer | Seattle, WA |
| George Saul | Director | Seattle, WA |
| Donna Jang | Director | Seattle, WA |
| Jason Pacanowsky | Executive Officer | Seattle, WA |
Other filings by this issuer (5)
More